Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T Burton
Estimating the Cost Per Percent Point Reduction in LDL-C for Patients Treated With Pcsk9 Inhibitors in a Large National Health Plan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Unnecessary Tetanus Boosters in the ED
Emergency Medicine Journal
Medicine
Critical Care
Emergency Medicine
Intensive Care Medicine
Related publications
Are PCSK9 Inhibitors Cost Effective?
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors.
Cardiologia Croatica
Cardiovascular Medicine
Cardiology
Effects of Currently Prescribed LDL-C-lowering Drugs on PCSK9 and Implications for the Next Generation of LDL-C-lowering Agents
Lipids in Health and Disease
Biochemistry
Endocrinology
Clinical Biochemistry
Metabolism
Diabetes
A National Plan for Health Service
American Journal of Public Health
Cost Per Response/Remission in Biologics Available in Italy for the Treatment of TNF-α Inhibitors-Naïve Patients With Ulcerative Colitis
Global and Regional Health Technology Assessment
Health Policy
Rush to Judgement: Imaginary Worlds and Cost-Outcomes Claims for PCSK9 Inhibitors
INNOVATIONS in pharmacy
Changes in Serum LDL, PCSK9 and microRNA‑122 in Patients With Chronic HCV Infection Receiving Daclatasvir/Asunaprevir
Biomedical Reports
Genetics
Pharmacology
Molecular Biology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Estimating the Cost of Liver Transplantation in Patients Diagnosed With Chronic Hepatitis C and B in the Uk
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PCSK9 Inhibitors: A Technology Worth Paying For?
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
